-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A group of engineers, doctors and computer scientists from the Massachusetts Institute of Technology (MIT) has posted a ventilator emergency project online, saying it is working on a low-cost ventilator alternative that could be quickly adopted globally
.
In response to the new crown pneumonia epidemic, they established a ventilator emergency team called MIT E-VENT
.
This project is actually based on an invention 10 years ago
.
In response to the current severe global epidemic, they quickly restarted this research work
.
The key to this simple, low-cost ventilator alternative is a manually-operated plastic bag called the Bag-Valve Resuscitator or Ambu Bag, which hospitals already use heavily
.
This design can be manually operated by a medical professional or emergency technician to provide oxygen to patients in critical situations such as cardiac arrest
.
Like a hospital ventilator, the simple ventilator involves intubating a patient's airway and then pumping air into the lungs by squeezing and releasing a flexible bag
.
Currently, the MIT team is designing a mechanical system to squeeze and release the Ambu bag, which would avoid manual manipulation
.
Although this is just a simple solution, the MIY team said that this is not a DIY thing, but a medical device that has been repeatedly demonstrated and tested by many professionals, and needs to be used under the supervision of professional doctors
.
Manufacturing standards also follow FDA regulations
.
According to MIT's official website, this simple ventilator has been improved and is currently undergoing functional testing
.
The research team has submitted an application to the FDA and is awaiting feedback from the FDA
.
